| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.8M | — | +0.3% |
| Cost of Revenue | $1.5M | — | +13.5% |
| Gross Profit | $1.3M | — | -11.0% |
| R&D Expense | $4.4M | — | +42.7% |
| SG&A Expense | $1.9M | — | +4.9% |
| Operating Income | -$7.1M | — | -31.8% |
| Pre-tax Income | -$7.0M | — | -30.8% |
| Income Tax | $0 | — | — |
| Net Income | -$7.0M | — | -30.8% |
| EPS (Basic) | -$0.15 | — | +94.0% |
| EPS (Diluted) | -$0.15 | — | +94.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $1.9M | -22.9% | — |
| Inventory | $3.5M | +16.9% | — |
| Current Assets | $24.5M | +47.0% | — |
| Total Assets | $25.9M | +42.8% | — |
| Current Liabilities | $5.4M | +21.1% | — |
| Total Liabilities | $5.7M | +16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.1M | — | -21.7% |
| Capital Expenditures | $48K | — | +20.0% |
| Investing Cash Flow | -$48K | — | -20.0% |
| Financing Cash Flow | $14.0M | — | — |
| Free Cash Flow | -$6.1M | — | -21.6% |
| Stockholders' Equity | $20.2M | +52.5% | +115.0% |